| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 14.585 | 38.460 | 35.688 | 29.635 | 13.969 | 30.104 | 38.624 | 49.900 | 59.862 |
| Total Income - EUR | - | 14.882 | 39.511 | 35.688 | 29.635 | 14.453 | 30.104 | 38.624 | 90.333 | 60.611 |
| Total Expenses - EUR | - | 4.065 | 15.804 | 10.337 | 17.376 | 15.950 | 7.651 | 29.650 | 75.333 | 32.331 |
| Gross Profit/Loss - EUR | - | 10.817 | 23.707 | 25.351 | 12.259 | -1.497 | 22.453 | 8.974 | 14.999 | 28.279 |
| Net Profit/Loss - EUR | - | 10.525 | 23.323 | 24.994 | 11.963 | -1.580 | 21.813 | 7.908 | 14.096 | 26.461 |
| Employees | - | 1 | 0 | 1 | 1 | 1 | 1 | 0 | 1 | 1 |
Check the financial reports for the company - Oftalmich Diagnostic S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 621 | 533 | 21.225 | 35.207 | 32.279 | 36.703 | 80.549 | 20.756 | 34.073 |
| Current Assets | - | 11.104 | 29.523 | 27.208 | 24.027 | 19.167 | 30.221 | 15.636 | 15.352 | 6.905 |
| Inventories | - | 0 | 0 | 1.252 | 4.240 | 4.892 | 5.621 | 5.898 | 6.627 | 500 |
| Receivables | - | 637 | 0 | 0 | 10.741 | 0 | 93 | 0 | 15 | 3.371 |
| Cash | - | 10.467 | 29.523 | 25.957 | 9.046 | 14.274 | 24.507 | 9.738 | 8.710 | 3.034 |
| Shareholders Funds | - | 10.570 | 23.376 | 47.941 | 58.975 | 50.837 | 66.468 | 63.910 | 28.510 | 25.854 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 1.155 | 6.680 | 493 | 258 | 609 | 455 | 32.275 | 7.599 | 15.123 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Oftalmich Diagnostic S.r.l.